Company & Sponsor Intelligence

University of Southern California

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials8

Recruiting0

Completed7

Countries1

Therapeutic footprint

alzheimersautismdementia_otherdepressionpain_neuropathystroke

Indexed studies

NCT01767909The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)
alzheimers · United StatesPHASE2, PHASE3

NCT01231971Alzheimer's Disease Neuroimaging Initiative 2
alzheimers · United StatesCOMPLETED

NCT02488720Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
dementia_other · United StatesCOMPLETED

NCT03104816The Effectiveness of IV/PO Acetaminophen in the Perioperative Period in Reducing Opiate Use After Lumbar Spine Fusion
pain_neuropathy · United StatesPHASE4

NCT02430051Sensory Adapted Dental Environments to Enhance Oral Care for Children
autism · United StatesNA

NCT00709150Collaborative Depression Care Management in Treating Depressed Low-income Hispanics With Diabetes
depression · United StatesPHASE4

NCT05602220Heart Rate and Breathing Effects on Attention and Memory
alzheimers · United StatesNA

NCT05029193Effectiveness of Mindfulness After a Stroke
stroke · United StatesNA

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →